Prevalence of lysosomal storage diseases in Portugal
- PMID: 14685153
- DOI: 10.1038/sj.ejhg.5201044
Prevalence of lysosomal storage diseases in Portugal
Abstract
Lysosomal storage diseases (LSDs) are a group of inherited metabolic disorders individually considered as rare, and few data on its prevalence has been reported in the literature. The overall birth prevalence of the 29 different LSDs studied in the Portuguese population was calculated to be 25/100000 live births, twice the prevalence previously described in Australia and in The Netherlands. The comparison of the prevalence profile of the LSDs presenting a prevalence higher than 0.5/100000 in the Portuguese, Dutch and Australian populations showed, in the Portuguese, the existence of a higher prevalence of GM2 gangliosidoses (B variant), mucolipidoses (II and III), Niemman-Pick type C and metachromatic leukodystrophy (MLD), and a lower prevalence of Pompe and Fabry. The highest prevalence value for a single LSD is the one of GM2 gangliosidoses (B variant), corresponding to 3/100000, a value which is significantly higher than the prevalence of the most frequent LSD in Dutch, Pompe disease (2/100000) and Australians, Gaucher's disease (GD) (1.8/100000). It is worth noting that the highest prevalence of GM2 gangliosidoses found in the Portuguese is mainly due to the existence of a unique subtype, the rare juvenile B1 variant.
Similar articles
-
The frequency of lysosomal storage diseases in The Netherlands.Hum Genet. 1999 Jul-Aug;105(1-2):151-6. doi: 10.1007/s004399900075. Hum Genet. 1999. PMID: 10480370
-
Lysosomal storage diseases in Greece.Genet Couns. 1995;6(1):43-7. Genet Couns. 1995. PMID: 7794561
-
Immune system irregularities in lysosomal storage disorders.Acta Neuropathol. 2008 Feb;115(2):159-74. doi: 10.1007/s00401-007-0296-4. Epub 2007 Oct 9. Acta Neuropathol. 2008. PMID: 17924126 Review.
-
The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations.J Inherit Metab Dis. 2010 Aug;33(4):387-96. doi: 10.1007/s10545-010-9093-7. Epub 2010 May 20. J Inherit Metab Dis. 2010. PMID: 20490927 Free PMC article.
-
Neurological manifestations in lysosomal storage disorders - from pathology to first therapeutic possibilities.Neuropediatrics. 2005 Oct;36(5):285-9. doi: 10.1055/s-2005-872810. Neuropediatrics. 2005. PMID: 16217702 Review.
Cited by
-
Uncovering a New Family Cluster of Gaucher Disease: A Case Report.Cureus. 2024 Jan 3;16(1):e51604. doi: 10.7759/cureus.51604. eCollection 2024 Jan. Cureus. 2024. PMID: 38313996 Free PMC article.
-
Frequency of Fabry disease in male and female haemodialysis patients in Spain.BMC Med Genet. 2010 Feb 1;11:19. doi: 10.1186/1471-2350-11-19. BMC Med Genet. 2010. PMID: 20122163 Free PMC article.
-
In vivo delivery of human acid ceramidase via cord blood transplantation and direct injection of lentivirus as novel treatment approaches for Farber disease.Mol Genet Metab. 2008 Nov;95(3):133-41. doi: 10.1016/j.ymgme.2008.08.003. Epub 2008 Sep 20. Mol Genet Metab. 2008. PMID: 18805722 Free PMC article.
-
Fabry disease, enzyme replacement therapy and the significance of antibody responses.J Inherit Metab Dis. 2012 Mar;35(2):227-43. doi: 10.1007/s10545-011-9400-y. Epub 2011 Oct 25. J Inherit Metab Dis. 2012. PMID: 22037707 Review.
-
Current and emerging treatments and surgical interventions for Morquio A syndrome: a review.Res Rep Endocr Disord. 2012 Dec;2012(2):65-77. doi: 10.2147/RRED.S37278. Res Rep Endocr Disord. 2012. PMID: 24839594 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources